Medical cannabis company IM Cannabis Corp IMCNF IMCC, a multi-country operator with presence in Israel and several European countries, announced earlier this week that its German subsidiary will provide IMC branded medical cannabis products to Zur Rose Pharma GmbH over the next year.
Zur Rose Pharma is a large German pharmaceutical wholesaler and distributor licensed for the supply of medical cannabis. It is part of Zur Rose Group AG ZRSEF, Europe’s largest e-pharmacy.
The purchase commitment between Adjupharm GmbH and Zur Rose GmbH is part of a longer-term sales agreement. it marks IMC’s fourth consecutive deal with a German medical cannabis distributor.
“Securing the three-year sales agreement with Zur Rose and its purchase commitment for IMC branded products are part of our growth strategy in the burgeoning German medical cannabis market," IM Cannabis CEO Oren Shuster told Benzinga. “Partnering with a European e-pharmacy powerhouse like Zur Rose also bears the potential for future expansion of the IMC brand presence across the continent as a leading provider of high-quality medical cannabis products."
Photo: Javier Hasse.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
The Benzinga Cannabis Capital Conference is coming to Florida
The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.
Get your tickets now on bzcannabis.com – Prices will increase very soon!